QualityStocks would like to highlight MRI Interventions, Inc. (OTCBB:MRIC), creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared ClearPoint® system is designed to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace™ system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.
In the company’s news yesterday,
MRI Interventions announced the first use of the company’s ClearPoint® system in an MRI-guided brain biopsy.
The system provides physicians with guidance for the placement and operation of surgical instruments used during neurological magnetic resonance imaging (MRI) procedures. Simply put, when a physician uses the ClearPoint system, he/she aims the system at the neurological target of choice, and watches via MRI as the surgical instrument is advanced to the target.
ClearPoint is applicable for a range of procedures, including biopsies and catheter and electrode insertions, and is designed to work in collaboration with a hospital’s existing MRI suite.
The procedure was performed at MD Anderson in Houston, Texas, where neurosurgeon Dr. Ashwin Viswanathan and Dr. Sujit Prabhu utilized the integrated system of reusable components, disposable components, and intuitive, menu-driven software.
“The system worked well,” Dr. Prabhu stated in the press release. “The clear advantage is confirming the position of the needle tip prior to a biopsy and also identifying a safe trajectory to the lesion.”
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.